Antimicrobial in vitro activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa - a pilot Bulgarian study

被引：17
|
作者：
Savov, Encho [1 ]
Trifonova, Angelina [1 ]
Kovachka, Krassimira [2 ]
Kjosseva, Elena [1 ]
Strateva, Tanya [3 ]
机构：
[1] Mil Med Acad, Dept Mil Epidemiol & Hyg, Microbiol Lab, Sofia, Bulgaria
[2] Multiprofile Hosp Act Treatment, Samokov, Bulgaria
[3] Med Univ Sofia, Fac Med, Dept Med Microbiol, Sofia, Bulgaria
来源：
INFECTIOUS DISEASES | 2019年 / 51卷 / 11-12期
关键词：
GRAM-NEGATIVE BACTERIA; INFECTIONS;
D O I：
10.1080/23744235.2019.1653491
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：870 / 873
页数：4
相关论文
共 50 条
  • [31] IN VITRO ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COLISTIN AGAINST CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES
    Hosbul, Tugrul
    Aydogan, Canset Nur
    Kaya, Sinem
    Bedir, Rhan
    Ozcan, Hande
    Gumral, Ramazan
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022, 85 (03): : 355 - 361
  • [32] Evaluation of the In vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Bilgin, Melek
    Basbulut, Ese
    Isler, Hacer
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 713 - 719
  • [33] Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study
    Almangour, Thamer A.
    Ghonem, Leen
    Alassiri, Dareen
    Aljurbua, Alanoud
    Al Musawa, Mohammed
    Alharbi, Aminah
    Almohaizeie, Abdullah
    Almuhisen, Sara
    Alghaith, Jeelan
    Damfu, Nader
    Aljefri, Doaa
    Alfahad, Wafa
    Khormi, Yaqoub
    Alanazi, Menyfah Q.
    Alsowaida, Yazed Saleh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (08)
  • [34] In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa
    Pires, Joao
    Siriwardena, Thissa N.
    Stach, Michaela
    Tinguely, Regula
    Kasraian, Sara
    Luzzaro, Francesco
    Leib, Stephen L.
    Darbre, Tamis
    Reymond, Jean-Louis
    Endimiani, Andrea
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (12) : 7915 - 7918
  • [35] In Vitro Activities of Various Antimicrobials Against Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Strains Isolated from Intensive Care Units
    Senol, Arzu
    Celik, Ilhami
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (01): : 96 - 103
  • [36] Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro
    Kobayashi, Yoshio
    Sumitani, Yuko
    Sugita, Kayoko
    Aikawa, Naoki
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (06) : 563 - 564
  • [37] In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
    Ferrari dos Santos Lima, Denissani Aparecida
    Passeri do Nascimento, Margarida Maria
    Vitali, Lucia Helena
    Martinez, Roberto
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2013, 46 (03) : 299 - 303
  • [38] Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
    Sader, Helio S.
    Castanheira, Mariana
    Duncan, Leonard R.
    Mendes, Rodrigo E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 279 - 281
  • [39] Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report
    Almangour, Thamer A.
    Alsubaie, Sarah
    Ghonem, Leen
    Almohaini, Hissah A.
    Bakheet, Hind Mohammed
    Altweijri, Ikhlass
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (05) : 436 - 438
  • [40] Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam
    Atkin, Stan D.
    Abid, Shadaan
    Foster, Michael
    Bose, Moumita
    Keller, Ashley
    Hollaway, Rita
    Sader, Helio S.
    Greenberg, David E.
    Finklea, James D.
    Castanheira, Mariana
    Jain, Raksha
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 1499 - 1510
12345